Evaluation of a western blot serum test for the diagnosis of Mycobacterium tuberculosis infection

This study was designed to evaluate the possibility of monitoring Mycobacterium tuberculosis infection using a serological assay. A discriminant score comprising antigen fractions of 38, 28, 24 and 19 kDa, identified in western blots using the Mycobacterium bovis bacille Calmette-Guerin (BCG) A60 antigen complex was established in a sample of 57 purified protein derivative (PPD)-negative and 47 PPD-positive individuals. It was then tested in a group of 140 subjects undergoing BCG vaccination as a model of tuberculosis complex infection and in a group of human immunodeficiency virus (HIV)-infected individuals as a model of cell-mediated immunodeficiency-related risk of tuberculosis. The discriminant score identified 57 out of 57 (100%) PPD-positives and none (0%) of the 47 PPD-negatives. In the BCG vaccinated subjects, 1.4% tested positive before vaccination and 90% after vaccination. In the HIV-positive subjects, 90% of the PPD-positive and 5% of the PPD-negative subjects had a positive score. This study suggests that the western blot discriminant score is an accurate test to survey M. tuberculosis infection in serum samples.

This article has been cited by other articles:

				B. L. Anderson, R. J. Welch, and C. M. Litwin Assessment of Three Commercially Available Serologic Assays for Detection of Antibodies to Mycobacterium tuberculosis and Identification of Active Tuberculosis Clin. Vaccine Immunol., November 1, 2008; 15(11): 1644 - 1649. [Abstract] [Full Text] [PDF]

				R. L. Hong Lim, L. Kiang Tan, W. Fun Lau, M. Ching Ming, Chung, R. Dunn, H. Phon Too, and L. Chan Cloning and Expression of Immunoreactive Antigens from Mycobacterium tuberculosis Clin. Vaccine Immunol., July 1, 2000; 7(4): 600 - 606. [Abstract] [Full Text] [PDF]